Loading…
INSMED Inc announced its Q2 financial results and updated FY2026 sales guidance on August 6, 2026.
INSMED Inc announced on 2026-08-06 INSM reported Q2 financial results and raised FY2026 sales guidance.
FY2026 Sales Guidance $1.700B-$1.870B. Previous FY2026 Sales Guidance $1.450B-$1.470B. The announcement cited Q2 EPS $(0.06), Q2 EPS Estimate $(0.73), Q2 Sales $425.486M, Q2 Sales Estimate $392.836M, and FY2026 Sales Estimate $1.705B. Related filings: https://www.sec.gov/Archives/edgar/data/1104506/000114036126031502/0001140361-26-031502-index.htm.
INSMED Inc has a free float of 198,421,696 shares and 216,752,451 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.